1. X
  2. BostonSci Cardiology
Log inSign up
BostonSci Cardiology
9,699 posts
Image
user avatar
BostonSci Cardiology
@BSCCardiology
Boston Scientific Cardiology. We invite physicians in the U.S. to learn about our cardiology & electrophysiology therapies and devices. bit.ly/2cOqgdl
St Paul, MN
bostonscientific.com/en-US/home.html
Joined March 2016
3,017
Following
27.7K
Followers
RepliesRepliesMediaMedia

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Sep 3, 2019
    You may be able to predict potential heart failure events weeks in advance. Discover HeartLogic™ here: bddy.me/2UsGDBB
    Image
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    May 8, 2019
    We’re excited to see you at our booth at #HRS2019 Stop by today.
    Image
    Image
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Jan 10, 2019
    We’re introducing a brand new #MedEd program for EP fellows that explores significant moments in EP history, offers hands-on experience & previews what’s to come. If you’re an EP fellow or a Director of an EP program with EP fellows who may be interested, send us a DM. #CardioEd
    Image
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Oct 6, 2021
    We’re excited to announce that we’ve agreed to acquire @BaylisMedical. Their portfolio of left heart access solutions will support our efforts to improve procedural efficiencies with tools designed to make left atrial access safer and more predictable bit.ly/3DbgpIM $BSX
    Image
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    May 9, 2018
    Now published: Cost effectiveness of left atrial appendage closure with the WATCHMAN Device compared to warfarin for stroke risk reduction in NVAF patients with a prior stroke now published in the Stroke journal! #LAAC #LAA @American_Heart stroke.ahajournals.org/content/early/…
    Image
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Jan 31, 2024
    The FARAPULSE™ Pulsed Field Ablation System is now FDA approved! FARAPULSE™ offers tissue selective cardiac #ablation for the treatment of PAF which minimizes thermal risk. See the FARAPULSE™ difference: bostonscientific.com/en-US/products… Safety info: bit.ly/47VaqXO
    Image
    00:00
    9.5K09.5K
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Feb 25, 2025
    The first-ever FARAFLEX™ Mapping and Pulsed Field Ablation (PFA) Catheter case was completed at KBC Split in Split, Croatia as part of the premarket ELEVATE-PF feasibility study performed by Dr. Anic and observed by Drs. Wazni and Saliba. Our innovation and clinical investment
    Image
    00:00
    12K012K
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Dec 6, 2024
    Watch how an electroanatomical map was able to be quickly created using the FARAWAVE™ NAV PFA Catheter using the flower and basket configurations on the FARVIEW™ Software Module, by Dr. Mike Manogue and the Mission Hospital team. This map assisted in the PVI ablation for a
    Image
    00:00
    10K010K
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Sep 2, 2019
    #Heartfailure rates are expected to increase by 46% by 2030. This case study featured in @EPLabDigest reviews how a multisensor heart failure diagnostic can reduce potential hospital readmissions due to #HF. bddy.me/34kUcaA IMPORTANT SAFETY INFO: bddy.me/34ePJWZ
    Image
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    May 2, 2019
    Boston Scientific Announces Scheduled Presentations at #HRS2019 bddy.me/2UYjWni
    Image
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Nov 16, 2024
    PRIMARY ENDPOINTS MET! We are excited to announce the positive results from OPTION Clinical Trial – the primary endpoints showed WATCHMAN FLX™ was equally effective to OACs, with a superior safety profile at 36 months, which allowed patients to eliminate continuous medication
    Image
    9.3K09.3K
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Feb 15, 2024
    1/ Today we want to celebrate the first US commercial cases using the FARAPULSE™ PFA System. To kick us off, congrats to Dr. @VivekReddyMD and the team at @MountSinaiHeart for being a part of this milestone and completing your first commercial FARAPULSE™ cases!
    Image
    11K011K
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Jul 21, 2020
    We are excited to announce FDA approval for the WATCHMAN FLX™ Left Atrial Appendage Closure Device to reduce stroke risk for patients with non-valvular #AFib who need an alternative to oral anticoagulation: bit.ly/32H2LOQ #LAAC Safety info: bit.ly/32EJHAz
    Image
    GIF
  • user avatar
    BostonSci Cardiology
    @BSCCardiology
    Oct 29, 2024
    The next-level FARAPULSE™ mapping experience is here! The first FARAVIEW™ cases are officially beginning in the United States. We’re excited to provide physicians the next leap forward in mapping for the leading PFA system and to deliver confidence in PFA visualization. Learn
    Image
    00:00
    6.9K06.9K
Advertisement
Advertisement